• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

ASO Author Reflections: Does AI Guided Endoscopic Response Evaluation After Neoadjuvant Chemotherapy Encourage Individualized Treatment Strategy in Esophageal Cancer Patients?

作者信息

Matsuda Satoru, Irino Tomoyuki, Kawakubo Hirofumi, Takeuchi Masashi, Nishimura Erika, Hisaoka Kazuhiko, Sano Junichi, Kobayashi Ryota, Fukuda Kazumasa, Nakamura Rieko, Takeuchi Hiroya, Kitagawa Yuko

机构信息

Department of Surgery, Keio University School of Medicine, Tokyo, Japan.

Department of Surgical and Perioperative Sciences, Surgery, Umeå University, Umeå, Sweden.

出版信息

Ann Surg Oncol. 2023 Jun;30(6):3743-3744. doi: 10.1245/s10434-023-13198-9. Epub 2023 Mar 2.

DOI:10.1245/s10434-023-13198-9
PMID:36864323
Abstract
摘要

相似文献

1
ASO Author Reflections: Does AI Guided Endoscopic Response Evaluation After Neoadjuvant Chemotherapy Encourage Individualized Treatment Strategy in Esophageal Cancer Patients?ASO作者反思：新辅助化疗后人工智能引导的内镜反应评估是否鼓励食管癌患者采取个体化治疗策略？
Ann Surg Oncol. 2023 Jun;30(6):3743-3744. doi: 10.1245/s10434-023-13198-9. Epub 2023 Mar 2.
2
ASO Author Reflections: Preoperative Prediction of Pathological Complete Response Using Deep Neural Network After Neoadjuvant Chemotherapy in Esophageal Cancer Patients.ASO作者反思：食管癌患者新辅助化疗后使用深度神经网络对病理完全缓解进行术前预测
Ann Surg Oncol. 2023 Nov;30(12):7509-7510. doi: 10.1245/s10434-023-13948-9. Epub 2023 Jul 13.
3
Evaluation of Endoscopic Response Using Deep Neural Network in Esophageal Cancer Patients Who Received Neoadjuvant Chemotherapy.使用深度神经网络评估接受新辅助化疗的食管癌患者的内镜反应。
Ann Surg Oncol. 2023 Jun;30(6):3733-3742. doi: 10.1245/s10434-023-13140-z. Epub 2023 Mar 2.
4
ASO Author Reflections: Prediction of the Therapeutic Efficacy in Patients with Neoadjuvant Chemotherapy for Esophageal Squamous Cell Carcinoma.ASO作者反思：食管鳞状细胞癌新辅助化疗患者治疗疗效的预测
Ann Surg Oncol. 2020 Dec;27(Suppl 3):795-796. doi: 10.1245/s10434-020-08772-4. Epub 2020 Jun 26.
5
ASO Author Reflections: Response to Neoadjuvant Chemotherapy Strengthens the Prognostic Impact of Pathological Stage for Esophageal Squamous Cell Carcinoma.ASO作者反思：对新辅助化疗的反应增强了病理分期对食管鳞状细胞癌的预后影响。
Ann Surg Oncol. 2021 Dec;28(13):8448-8449. doi: 10.1245/s10434-021-10231-7. Epub 2021 Jun 18.
6
ASO Author Reflections: Prediction of the Response to Neoadjuvant Therapy by Patients with Esophageal Squamous Cell Carcinoma.ASO作者反思：食管鳞状细胞癌患者对新辅助治疗反应的预测
Ann Surg Oncol. 2023 Apr;30(4):2186-2187. doi: 10.1245/s10434-022-12962-7. Epub 2022 Dec 20.
7
ASO Author Reflections: Risk for Three-Course Neoadjuvant Chemotherapy in Advanced Esophageal Cancer.ASO作者反思：晚期食管癌三疗程新辅助化疗的风险
Ann Surg Oncol. 2023 Sep;30(9):5908-5909. doi: 10.1245/s10434-023-13558-5. Epub 2023 Jun 8.
8
ASO Author Reflections: Lymph Node Ratio After Neoadjuvant Chemotherapy in Locally Advanced Esophageal Cancer.ASO作者反思：局部晚期食管癌新辅助化疗后的淋巴结比率
Ann Surg Oncol. 2021 Dec;28(13):8473. doi: 10.1245/s10434-021-10394-3. Epub 2021 Jul 1.
9
ASO Author Reflections: Prognosis of Esophageal Cancer After Neoadjuvant Therapy: A More Accurate Evaluation System is Needed.ASO作者反思：新辅助治疗后食管癌的预后：需要一个更准确的评估系统。
Ann Surg Oncol. 2024 Jan;31(1):239-240. doi: 10.1245/s10434-023-14363-w. Epub 2023 Sep 30.
10
Response evaluation by endoscopy, rebiopsy, and endoscopic ultrasound does not accurately predict histopathologic regression after neoadjuvant chemoradiation for esophageal cancer.通过内镜检查、再次活检和内镜超声进行的反应评估不能准确预测食管癌新辅助放化疗后的组织病理学消退情况。
Ann Surg. 2008 Dec;248(6):902-8. doi: 10.1097/SLA.0b013e31818f3afb.

本文引用的文献

1
Nationwide Validation Study of the Prognostic Significance of Stratification Using Pathological Stage and Response to Neoadjuvant Chemotherapy for Esophageal Squamous Cell Carcinoma.食管癌鳞状细胞癌病理分期及新辅助化疗反应分层预后意义的全国性验证研究
Ann Surg. 2023 Aug 1;278(2):e234-e239. doi: 10.1097/SLA.0000000000005701. Epub 2022 Oct 29.
2
Clinical Significance of Endoscopic Response Evaluation to Predict the Distribution of Residual Tumor after Neoadjuvant Chemotherapy for Esophageal Squamous Cell Carcinoma.内镜反应评估对预测食管鳞癌新辅助化疗后残余肿瘤分布的临床意义。
Ann Surg Oncol. 2022 Apr;29(4):2673-2680. doi: 10.1245/s10434-021-11009-7. Epub 2021 Nov 23.